QA: Pyxis Oncology Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001782223_2023_Pyxis_Oncology_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001782223, Pyxis Oncology Inc.

  xvar xval
0 AssetsCurrent 186,612,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 11,165,000
3 remainder_Assets 13,602,000
4 LiabilitiesCurrent 31,634,000
5 LiabilitiesNoncurrent 18,921,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 37,352,000
9 ResearchAndDevelopmentExpense 86,129,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 2,764,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 211,379,000
1 Liabilities 50,555,000
2 Expenses 123,481,000
3 Revenues 0
4 StockholdersEquity 160,824,000
5 NetIncome -120,717,000
6 ComprehensiveNetIncome -120,717,000
7 BaseVar 194,089,500
8 EconomicCapitalRatio 1.19

Edgar->Model Mapping

Feature Distribution

Change over Time